Cargando…
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
BACKGROUND: Microvascular and macrovascular thrombotic events are among the hallmarks of coronavirus disease 2019 (COVID-19). Furthermore, the exuberant immune response is considered an important driver of pulmonary and extrapulmonary manifestations of COVID-19. The optimal management strategy to pr...
Ejemplares similares
-
Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19: Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals
por: Talasaz, Azita H., et al.
Publicado: (2022) -
Pharmacokinetics Alterations of Midazolam Infusion versus Bolus Administration in Mechanically Ventilated Critically Ill Patients
por: Beigmohammadi, Mohammad Taghi, et al.
Publicado: (2013) -
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial
por: Rashidi, Farid, et al.
Publicado: (2022) -
Inspiration from inspirational cell biologists
por: Drubin, David G.
Publicado: (2014) -
Inspire
por: Simko, Tibor
Publicado: (2008)